RDRaminta Daniulaityte

Raminta Daniulaityte

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Raminta Daniulaityte has a total of 114 co-authors. Here are the top co-authors by number of shared publications:

  • Robert G. Carlson

    Center for Interventions, Treatment, and Addictions Research, Department of Population and Public Health Sciences, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, USA

    19 shared publications
  • Silvia Saboia Martins

    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA

    16 shared publications
  • Ramzi W. Nahhas

    Department of Population and Public Health Sciences, Boonshoft School of Medicine, Wright State University, United States of America; Department of Psychiatry, Boonshoft School of Medicine, Wright State University, United States of America

    15 shared publications
  • Francois Rene Lamy

    Department of Society and Health, Faculty of Social Sciences and Humanities, Mahidol University, Nakhon Pathom, Thailand

    14 shared publications
  • Amit Sheth

    10 shared publications
  • Robert G. Carlson

    Department of Population and Public Health Sciences, Boonshoft School of Medicine, Wright State University, United States of America

    10 shared publications

Latest Publications

  • Associations between kratom (Mitragyna Speciosa) use and real-time anxiety and sadness: A 15-day ecological momentary assessment study

    by Patricia Timmons, Raminta Daniulaityte, Leigh V. Panlilio, Kirsten E. Smith, David H. Epstein, Chung Jung Mun

  • Characteristics and Circumstances of US Overdose Deaths With Recorded Heat Involvement

    by Manuel Cano, Chung Jung Mun, Kaylin Sweeney, Raminta Daniulaityte

    Objectives: To examine the extent to which heat-related causes of death are recorded in fatal drug overdoses, how these patterns vary across states and over time, and how overdose characteristics differ between deaths with, versus without, heat involvement recorded. Methods: Death certificate data (from the National Center for Health Statistics) for all drug overdose deaths in US residents, 2001–2024, were analyzed to identify whether a heat-related cause of death was also listed on the death certificate. Joinpoint regression, descriptive statistics, and nonparametric tests were used to examine temporal trends and compare overdose deaths with versus without recorded heat involvement. Results: In 2001, fewer than 10 drug overdose deaths with recorded heat involvement were identified, but this number rose to 558 in 2024. Mortality rates for overdoses with recorded heat involvement increased from 2013 to 2024 with an estimated annual percent change of 30.1 (95% confidence interval, 26.5–47.1); the highest mortality rates and numbers of deaths were observed in residents of Arizona and Nevada. American Indian/Alaska Native, Mexican-heritage, and foreign-born populations accounted for larger shares of overdose deaths with, compared with without, heat involvement recorded. A street or highway was more frequently identified as the place of injury in overdose deaths with (18.9%), versus without (2.2%) heat involvement reported. Psychostimulants such as methamphetamine were involved in 85.9% of overdose deaths with, versus 28.9% without, recorded heat involvement. Conclusions: Although representing only a fraction of all overdose deaths, fatal overdoses with recorded heat involvement have increased, disproportionately impacting certain states and demographic groups.

  • “I knew that they weren't real pills from the doctor”: Characterizing consumer knowledge and experiences of identifying counterfeit pain pills in a fentanyl-saturated drug market

    by Raminta Daniulaityte, Kaylin Sweeney, Patricia Timmons, Madeline Hooten, Elisabeth Williams, Danielle Russell, Haley Coles, Matthew Juhascik

  • "I don't know how you can overdose smoking them:" Perceptions of overdose risks among persons who use illicit fentanyl-laced counterfeit pills

    by Raminta Daniulaityte, Kaylin Sweeney, Patricia Timmons, Madeline Hooten, Elisabeth Williams, Haley Coles, Danielle Russell, Frank LoVecchio


  • Open Access

    Authors’ Response to Peer Reviews of “Detecting Substance Use Disorder Using Social Media Data and the Dark Web: Time- and Knowledge-Aware Study”

    by Usha Lokala, Orchid Chetia Phukan, Triyasha Ghosh Dastidar, Francois Lamy, Raminta Daniulaityte, Amit Sheth

    This is the author(s)’ responses to peer review reports related to MS ID 48519

  • Open Access

    Detecting Substance Use Disorder Using Social Media Data and the Dark Web: Time- and Knowledge-Aware Study

    by Usha Lokala, Orchid Chetia Phukan, Triyasha Ghosh Dastidar, Francois Lamy, Raminta Daniulaityte, Amit Sheth

    Background: Opioid and substance misuse has become a widespread problem in the United States, leading to the “opioid crisis.” The relationship between substance misuse and mental health has been extensively studied, with one possible relationship being that substance misuse causes poor mental health. However, the lack of evidence on the relationship has resulted in opioids being largely inaccessible through legal means. Objectives: This study aims to analyze social media posts related to substance use and opioids being sold through cryptomarket listings. The study aims to use state-of-the-art deep learning models to generate sentiment and emotion from social media posts to understand users’ perceptions of social media. The study also aims to investigate questions such as which synthetic opioids people are optimistic, neutral, or negative about; what kind of drugs induced fear and sorrow; what kind of drugs people love or are thankful about; which drugs people think negatively about; and which opioids cause little to no sentimental reaction. Methods: The study used the drug abuse ontology and state-of-the-art deep learning models, including knowledge-aware Bidirectional Encoder Representations From Transformers–based models, to generate sentiment and emotion from social media posts related to substance use and opioids being sold through cryptomarket listings. The study crawled cryptomarket data and extracted posts for fentanyl, fentanyl analogs, and other novel synthetic opioids. The study performed topic analysis associated with the generated sentiments and emotions to understand which topics correlate with people’s responses to various drugs. Additionally, the study analyzed time-aware neural models built on these features while considering historical sentiment and emotional activity of posts related to a drug. Results: The study found that the most effective model performed well (statistically significant, with a macro–F1-score of 82.12 and recall of 83.58) in identifying substance use disorder. The study also found that there were varying levels of sentiment and emotion associated with different synthetic opioids, with some drugs eliciting more positive or negative responses than others. The study identified topics that correlated with people’s responses to various drugs, such as pain relief, addiction, and withdrawal symptoms. Conclusions: The study provides insight into users’ perceptions of synthetic opioids based on sentiment and emotion expressed in social media posts. The study’s findings can be used to inform interventions and policies aimed at reducing substance misuse and addressing the opioid crisis. The study demonstrates the potential of deep learning models for analyzing social media data to gain insights into public health issues.


  • Open Access

    Xylazine in Drug Seizure Reports and Overdose Deaths in the US, 2018-2022

    by Manuel Cano, Raminta Daniulaityte, Flavio Marsiglia

    Xylazine is increasingly reported in street drugs and fatal overdoses in the United States (US), often in combination with synthetic opioids, yet state-level xylazine data are limited, hampering local public health responses. The present study analyzed 2018-2022 state-level data from the National Forensic Laboratory Information System (xylazine-positive reports of seized drugs analyzed by forensic laboratories), the Centers for Disease Control and Prevention (population estimates, synthetic opioid overdose mortality rates), and individual states’ medical examiner/public health agency reports (numbers of xylazine-involved overdose deaths). An ordinary least squares regression model predicted state-level synthetic opioid overdose mortality rates by xylazine seizure report rates, adjusting for US Census Region. In 2018, relatively low rates of xylazine seizure reports were observed, with 21 states reporting zero xylazine seizures. In 2022, only three states reported zero xylazine seizures, and the highest xylazine seizure report rates (per 100,000 residents) were observed in New Jersey (30.4), Rhode Island (22.7), Maryland (18.9), Virginia (15.5), New Hampshire (13.0), and Ohio (10.9). Data on 2019-2022 xylazine-involved overdose deaths were available for 21 states/DC (60 state-years), with the highest 2022 xylazine-involved overdose death rates (per 100,000 residents) in Vermont (10.5) and Connecticut (9.8). Finally, in 2021, at the state level, each additional reported xylazine seizure per 100,000 residents was associated with a 2% higher synthetic opioid overdose mortality rate ( b =0.02, robust standard error=0.01; p =0.049). Overall, study results emphasize xylazine’s increasing involvement in US law enforcement drug seizure reports and overdose deaths, primarily in the East, yet also extending across the country.


  • Open Access

    "Can We Detect Substance Use Disorder?": Knowledge and Time Aware Classification on Social Media from Darkweb (Preprint)

    by Usha Lokala, Orchid Chetia Phukan, Triyasha Ghosh Dastidar, Francois Lamy, Raminta Daniulaityte, Amit Sheth

    UNSTRUCTURED Opioid and substance misuse is rampant in the United States today, with the phenomenon known as the "opioid crisis". The relationship between substance use and mental health has been extensively studied, with one possible relationship being: substance misuse causes poor mental health. However, the lack of evidence on the relationship has resulted in opioids being largely inaccessible through legal means. This study analyzes the substance use posts on social media with opioids being sold through crypto market listings. We use the Drug Abuse Ontology, state-of-the-art deep learning, and knowledge-aware BERT-based models to generate sentiment and emotion for the social media posts to understand users' perceptions on social media by investigating questions such as: which synthetic opioids people are optimistic, neutral, or negative about? or what kind of drugs induced fear and sorrow? or what kind of drugs people love or are thankful about? or which drugs people think negatively about? or which opioids cause little to no sentimental reaction. We discuss how we crawled crypto market data and its use in extracting posts for fentanyl, fentanyl analogs, and other novel synthetic opioids. We also perform topic analysis associated with the generated sentiments and emotions to understand which topics correlate with people's responses to various drugs. Additionally, we analyze time-aware neural models built on these features while considering historical sentiment and emotional activity of posts related to a drug. The most effective model performs well (statistically significant) with (macroF1=82.12, recall =83.58) to identify substance use disorder.